This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

International

Dec. 31, 2004

Building Biotech Bridges

SAN FRANCISCO - When Therascope was looking for more money to develop its products last year, the German biotechnology company's executives knew they couldn't rely solely on venture capital investors in their home country - no matter that Germany is among the world's leaders in biotech research and development.


By Erik Cummins
Daily Journal Staff Writer
        SAN FRANCISCO - When Therascope was looking for more money to develop its products last year, the German biotechnology company's executives knew they couldn't rely solely on venture capital investors in their home country - no matter that Germany is among the world's leaders in biotech research and d...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Sign up for Daily Journal emails